Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion

Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion

COVID-19 caused by SARS-Cov-2 is a devastating infection in patients with hematological malignancies. In 2018, the Lebanese Society of Hematology and Blood Transfusion (LSHBT) updated the guidelines for the management of hematological malignancies in Lebanon. In 2019, it was followed by a second upd...

Full description

Bibliographic Details
Main Authors: Ahmad Ibrahim, Peter Noun, Charbel Khalil, Ali Taher
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
SARS-Cov-2 infection
LSHBT
hematological malignancies
myeloid
lymphoid
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.564383/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.564383/full

Similar Items